BIOLASE, Inc.

BIOL · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$3,444$5,272$6,393$6,566
Short-Term Investments$0$0$0$0
Receivables$3,530$4,842$5,687$5,483
Inventory$9,870$10,904$11,273$11,433
Other Curr. Assets$2,584$1,076$1,652$1,381
Total Curr. Assets$19,428$22,094$25,005$24,863
Property Plant & Equip (Net)$4,627$5,364$6,159$7,044
Goodwill$2,926$2,926$2,926$2,926
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$260$257$263$268
Total NC Assets$7,813$8,547$9,348$10,238
Other Assets$0$0$0$0
Total Assets$27,241$30,641$34,353$35,101
Liabilities
Payables$3,001$5,491$4,915$6,065
Short-Term Debt$17,623$13,275$2,800$2,265
Tax Payable$386$349$383$452
Deferred Revenue$2,226$2,132$2,343$2,452
Other Curr. Liab.$1,437$2,616$3,780$1,363
Total Curr. Liab.$30,859$31,176$21,427$19,663
LT Debt$0$150$13,410$13,985
Deferred Rev, NC$220$186$223$256
Deferred Tax Liab, NC$0$0$0$772
Other NC Liab.$1,178$3,143$685-$1,531
Total NC Liab.$1,609$3,794$14,860$15,685
Other Liabilities$0$0$0$0
Cap. Leases$1,067$1,219$542$772
Total Liabilities$32,468$34,970$36,287$35,348
Equity
Pref Stock$0$0$2,203$2,203
Common Stock$36$33$33$3
Retained Earnings-$327,511-$326,083-$323,285-$316,800
AOCI-$530-$659-$639-$553
Other Equity$0$0-$2,203-$2,203
Total Equity-$5,227-$4,329-$1,934-$247
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$27,241$30,641$34,353$35,101
Net Debt$14,179$8,153$9,817$9,684